Long-Term Follow-Up Study of AAV2hAQP1 for Radiation Induced Xerostomia
NCT05060341 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 22
Last updated 2025-05-22
Summary
This study is a long-term follow-up study for patients who have been administered AAV2hAQP1 in the Phase 1 Open-Label, Dose Escalation Study to Determine the Optimal Dose, Safety, and Activity in Subjects with Radiation Induced Parotid Gland Hypofunction and Xerostomia
Conditions
- Radiation-induced Xerostomia
Sponsors & Collaborators
-
MeiraGTx, LLC
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Max Age
- 81 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-11-12
- Primary Completion
- 2027-03-31
- Completion
- 2027-03-31
Countries
- United States
- Canada
Study Locations
More Related Trials
-
Parotid-gland Stem-cell Sparing Intensity-modulated Radiotherapy
NCT01955239 ·Status: COMPLETED ·Phase: NA
-
Acupuncture-Like Transcutaneous Electrical Nerve Stimulation (ALTENS) or Pilocarpine in Treating Early Dry Mouth in Patients Undergoing Radiation Therapy for Head and Neck Cancer
NCT00656513 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Study of Circular RNA Treatment in Patients With Radiation Induced Xerostomia-1
NCT06714253 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Prospective Evaluation of Patient Reported Xerostomia After Whole Brain Radiation
NCT02682199 ·Status: COMPLETED
-
Sparing Parotid Ducts Via MRI Sialography for Reduced Patient-Reported Xerostomia
NCT07278557 ·Status: RECRUITING ·Phase: PHASE2
-
Controlled Trial Of Acupuncture To Prevent Radiation-Induced Xerostomia
NCT01266044 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Prevalence of Late Xerostomia and Hyposalivation with Associated Risk Factors in Survivors of Head and Neck Cancer After Radiotherapy: a Multi-centric Cross-sectional Study
NCT06851572 ·Status: COMPLETED
-
Prospective Study on Monitoring Parotid Gland Injury After Radiotherapy for Head and Neck Tumors Using Multimodal Radiomics
NCT06792526 ·Status: NOT_YET_RECRUITING
-
Salivary Gland Autotransplantation for Treatment of XRT Induced Xerostomia
NCT04007081 ·Status: COMPLETED ·Phase: NA
-
Acupuncture-Like Transcutaneous Electrical Nerve Stimulation in Treating Radiation-Induced Xerostomia in Patients With Head and Neck Cancer
NCT02474095 ·Status: COMPLETED ·Phase: NA
-
Impact on Xerostomia for Nasopharyngeal Carcinoma Patients Treated With or Without Superficial Parotid Lobe-sparing Intensity-modulated Radiotherapy
NCT05020067 ·Status: COMPLETED ·Phase: PHASE2
-
Everolimus in Restoring Salivary Gland Function in Participants With Locally Advanced Head and Neck Cancer Treated With Radiation Therapy
NCT03578432 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Electroacupuncture in Treating Chronic Dry Mouth Caused By Radiation Therapy in Patients With Head and Neck Cancer
NCT00623129 ·Status: TERMINATED ·Phase: NA
-
Functional Sparing of Salivary Glands Using MRI Sialography for Patients Undergoing Definitive Radiation Therapy for Head and Neck Cancers of the Oropharynx
NCT03418792 ·Status: COMPLETED ·Phase: NA
-
Trial of Acupuncture for Radiation-Induced Xerostomia in Head and Neck Cancer
NCT02589938 ·Status: COMPLETED ·Phase: NA
-
A Pilot Study to Evaluate the Feasibility of Combining Submandibular Salivary Gland Tx & IMRT Tomo to Reduce Xerostomia
NCT00497406 ·Status: UNKNOWN ·Phase: NA
-
Salivary Gland Surgery Before Radiation Therapy in Preventing Radiation-Caused Xerostomia in Patients With Head and Neck Cancer
NCT00068237 ·Status: COMPLETED ·Phase: PHASE2
-
Parotid-Sparing Intensity-Modulated Radiation Therapy Compared With Conventional Radiation Therapy in Treating Patients With Oropharyngeal or Hypopharyngeal Cancer Who Are at High Risk of Radiation-Induced Xerostomia
NCT00081029 ·Status: UNKNOWN ·Phase: PHASE3
-
Allogeneic Mesenchymal Stem Cells for Radiation-induced Hyposalivation and Xerostomia/Dry Mouth
NCT03874572 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Evaluation of Treatment Related Toxicity After Radiotherapy for Head and Neck Cancer
NCT01621048 ·Status: WITHDRAWN
-
Effects of Aqualief® in Patients With Xerostomia as Consequence of Radiotherapy for Head and Neck Cancer
NCT03601962 ·Status: TERMINATED ·Phase: NA
-
Mesenchymal Stem Cells for Radiation-induced Xerostomia
NCT03876197 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Oropharyngeal Function After Radiotherapy With IMRT
NCT00506324 ·Status: TERMINATED
-
Acupuncture for Prevention of Radiation-Induced Xerostomia
NCT00430378 ·Status: COMPLETED ·Phase: NA
-
Xerostomia in Head and Neck Cancer Patients Receiving Radiation as the Primary Treatment Versus Patients Who Will Not Have Such a Procedure
NCT00168116 ·Status: COMPLETED ·Phase: PHASE2